Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06718127

Description of the Immune Response to Yellow Fever Vaccination

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
38 (estimated)
Sponsor
Institut Pasteur · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Vaccine protection depends on a specific adaptive immune memory. However, a little-explored aspect of certain live vaccines may provide beneficial, non-specific protection against infections or pathogens other than the one from which the vaccine is derived. This is the concept of innate immune memory or " trained immunity", which differs from adaptive memory in its non-specificity. Innate immune memory is triggered by exposure to immunostimulants, and offers protection against unrelated pathogenic threats for several months or even years. The project aims to carry out an exploratory study to observe, in the context of current practice, the immune response obtained after a subunit and a live attenuated vaccine

Detailed description

Vaccine protection depends on a specific adaptive immune memory. However, a little-explored aspect of certain live vaccines may provide beneficial, non-specific protection against infections or pathogens other than the one from which the vaccine is derived. This is the concept of innate immune memory or " trained immunity", which differs from adaptive memory in its non-specificity. Innate immune memory is triggered by exposure to immunostimulants, and offers protection against unrelated pathogenic threats for several months or even years. For example, research has shown that the live attenuated BCG vaccine induce non-specific trained immunity, enabling innate immune cells to remember their first encounter and improve their immune status during a second confrontation with similar or different agents. Other currently available live vaccines, such as BCG , could also "train" innate immune cells. The project aims to carry out an exploratory study to observe, in the context of current practice, the immune response obtained after a subunit and a live attenuated vaccine

Conditions

Interventions

TypeNameDescription
BIOLOGICALblood samples collectionblood samples collected at D0 ,W1, W5, M3 and M6

Timeline

Start date
2024-09-30
Primary completion
2026-04-30
Completion
2027-04-30
First posted
2024-12-05
Last updated
2025-06-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06718127. Inclusion in this directory is not an endorsement.